Clinical trial

Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)

NCT03926520

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-01-28

PhaseNA

Study timeline

Study start (actual)2021-01-28Date precision: day

Registry last updated2026-07-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Dementiaunresolved

Agitation,Psychomotorunresolved

Interventions

Electroconvulsive Therapy (ECT)DEVICE

Sponsors & collaborators

Brent Foresterlead sponsor

Mayo Cliniccollaborator

Pine Rest Christian Mental Health Servicescollaborator

Emory Universitycollaborator

The Zucker Hillside Hospitalcollaborator

Medical University of South Carolinacollaborator

Mapped research locations

AtlantaGeorgia, United States1 RochesterMinnesota, United States1 Grand RapidsMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03926520 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.